According to Transpire Insight, the Global Point of Care Diagnostics Market is expanding rapidly due to rising chronic disease prevalence, an aging global population, and increasing demand for rapid bedside testing. Point of Care (POC) diagnostic devices enable immediate medical testing at or near the site of patient care, including hospitals, clinics, physician offices, urgent care centers, and home settings. Glucose monitoring, infectious disease testing, cardiometabolic testing, and coagulation monitoring constitute key application segments. As healthcare systems prioritize early disease detection, decentralized care models, and reduced turnaround times for diagnostic results, adoption of portable and connected POC diagnostic platforms continues to surge worldwide.

Market Size & Forecast

The Global Point of Care Diagnostics Market was valued at USD 48.25 Billion in 2025 and is projected to reach USD 92.60 Billion by 2033. Over the forecast timeframe from 2026 to 2033, the market is set to achieve a strong compound annual growth rate (CAGR) of 8.48%. Growth is heavily supported by continuous technological advancements in microfluidics, biosensors, molecular diagnostic testing, and digital healthcare connectivity.

Key Market Trends & Insights

• Infectious Disease & Molecular POC Expansion: Rapid molecular diagnostic devices, including microfluidic PCR cartridges and isothermal amplification platforms, are experiencing widespread clinical adoption for rapid viral and bacterial detection.
• Continuous Glucose Monitoring (CGM) Dominance: Blood glucose monitoring remains a major revenue driver, with wearable CGMs leading market adoption due to non-invasive features and real-time smartphone integration.
• Connectivity & EHR Integration: Modern POC diagnostic systems are increasingly equipped with Bluetooth, Wi-Fi, and cloud connectivity to seamlessly transfer patient test results directly into Electronic Health Records (EHR).
• Homecare & OTC Testing Growth: Patient preference for convenient home-based testing kits, supported by over-the-counter availability and telemedicine integration, is driving rapid market decentralization.

Regional Insights

• North America: Dominates the global market, backed by advanced healthcare infrastructure, high chronic disease prevalence, well-established reimbursement frameworks, and rapid adoption of novel diagnostic technologies.
• Asia Pacific: Foreseen as the fastest-growing regional market, propelled by expanding healthcare access, rising disposable incomes, large patient populations, and government health initiatives in China and India.